Cigna Group (NYSE:CI – Free Report) had its price objective increased by Wells Fargo & Company from $307.00 to $325.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have an equal weight rating on the health services provider’s stock.
Several other equities analysts have also recently weighed in on CI. Evercore began coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price objective on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $340.00 price objective on shares of Cigna Group in a report on Friday, November 6th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Sunday, November 8th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $337.00 target price on shares of Cigna Group in a report on Thursday, October 1st. Finally, Jefferies Financial Group increased their price target on shares of Cigna Group from $288.00 to $304.00 and gave the stock a “hold” rating in a research report on Thursday. Fourteen analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $336.90.
Read Our Latest Research Report on Cigna Group
Cigna Group Stock Performance
Shares of NYSE CI traded up $0.52 during midday trading on Friday, hitting $296.79. 1,442,187 shares of the stock traded hands, compared to its average volume of 1,681,560. The firm has a market capitalization of $78.21 billion, a P/E ratio of 13.10, a PEG ratio of 1.11 and a beta of 0.25. Cigna Group has a one year low of $257.85 and a one year high of $318.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a 50-day moving average of $287.53 and a two-hundred day moving average of $282.70.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, topping the consensus estimate of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The company had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. During the same quarter in the previous year, the company posted $7.83 earnings per share. Cigna Group’s revenue was up 5.6% compared to the same quarter last year. On average, equities analysts forecast that Cigna Group will post 30.71 EPS for the current fiscal year.
Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is 27.54%.
Insider Transactions at Cigna Group
In related news, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.
Institutional Trading of Cigna Group
Hedge funds and other institutional investors have recently modified their holdings of the company. Assetmark Inc. lifted its holdings in shares of Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after acquiring an additional 5,963 shares during the last quarter. Mystic Asset Management Inc. bought a new position in Cigna Group during the 2nd quarter valued at about $2,808,000. KBC Group NV grew its holdings in Cigna Group by 6.4% during the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after purchasing an additional 22,978 shares during the last quarter. Nykredit A S bought a new position in Cigna Group during the 2nd quarter valued at about $15,300,000. Finally, Sanctuary Advisors LLC purchased a new stake in Cigna Group in the 2nd quarter worth about $11,043,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
Cigna Group News Roundup
Investors following CI have been watching these news items:
- Positive Sentiment: Wells Fargo raised its price target from $307; reports give different new targets of $325 and $335, while keeping an equal-weight rating. Jefferies also lifted its target from $288 to $304, but maintained a hold rating. Wells Fargo target report Wells Fargo alternate target report Jefferies target report
- Positive Sentiment: Coverage points to a raised earnings outlook following a strong third quarter, which could improve expectations for future results. CIBC also included Cigna in a defensive stock-pick list. Cigna earnings outlook CIBC defensive stock-pick list
- Neutral Sentiment: Analyst sentiment remains moderately bullish overall, although coverage notes Cigna has lagged industry peers and the broader market. Analyst sentiment overview
Cigna Group Company Profile
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
Further Reading
- Five stocks we like better than Cigna Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
